Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28647159)
Watch
English
Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
title
Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
(English)
0 references
author name string
Irawati Kandela
series ordinal
1
0 references
James Chou
series ordinal
2
0 references
Kartoa Chow
series ordinal
3
0 references
language of work or name
English
0 references
publication date
22 May 2015
0 references
published in
eLife
0 references
volume
4
0 references
describes a project that uses
ImageJ
1 reference
stated in
Europe PubMed Central
retrieved
11 June 2022
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4441371/fullTextXML
based on heuristic
inferred from PubMed Central ID database lookup
cites work
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
7 April 2017
Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
3 June 2018
A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
3 June 2018
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
3 June 2018
RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
3 June 2018
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
3 June 2018
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
3 June 2018
Tissue-penetrating delivery of compounds and nanoparticles into tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441371
retrieved
3 June 2018
Tumor-penetrating peptides: a shift from magic bullets to magic guns.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.7554%2FELIFE.06959
retrieved
21 January 2018
Identifiers
DOI
10.7554/ELIFE.06959
0 references
PMCID
4441371
0 references
PubMed ID
27879198
0 references
25998055
reason for deprecated rank
unchecked identifier
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
